- |||||||||| sodium benzoate (EX039) / Excelsior
Trial completion date, Trial primary completion date: A Study of Oral EX039 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Sep 8, 2023
P2, N=120, Recruiting,
Trial completion date: Nov 2024 --> Feb 2027 | Trial primary completion date: Aug 2024 --> Aug 2025
- |||||||||| sodium benzoate (EX039) / Excelsior
Enrollment open: A Study of Oral EX039 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Feb 15, 2023
P2, N=120, Recruiting,
Trial completion date: Nov 2024 --> Feb 2027 | Trial primary completion date: Aug 2024 --> Aug 2025 Not yet recruiting --> Recruiting
|
